Synthetic niches for differentiation of human embryonic stem cells bypassing embryoid body formation

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 102, Issue 5, 2014, Pages 1101-1112

  Liu, Yarong ^a   Fox, Victoria ^b   Lei, Yuning ^a   Hu, Biliang ^a   Joo, Kye Il ^a   Wang, Pin ^a,c  

^a University of Southern California   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

differentiation; embryoid body; human embryonic stem cell; polymer scaffold; transplantation

Indexed keywords

CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COPOLYMERS; DIFFERENTIATION (CALCULUS); STEM CELLS; TRANSPLANTATION (SURGICAL);

BIODEGRADABLE POLYMER SCAFFOLDS; DIRECTED DIFFERENTIATIONS; EMBRYOID BODY; HIGHER-ORDER STRUCTURE; HUMAN EMBRYONIC STEM CELLS; POLY(LACTIC-CO-GLYCOLIC ACID); POLYMER SCAFFOLDS; THREE-DIMENSIONAL CULTURE;

SCAFFOLDS (BIOLOGY);

GROWTH FACTOR; POLYGLACTIN; POLYMER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; GERM LAYER; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MICROENVIRONMENT; MONOLAYER CULTURE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POROSITY; STEM CELL NICHE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; CELL LINE; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; PROCEDURES; TISSUE SCAFFOLD;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; EMBRYOID BODIES; EMBRYONIC STEM CELLS; HUMANS; LACTIC ACID; PLURIPOTENT STEM CELLS; POLYGLYCOLIC ACID; STEM CELL NICHE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84902499447     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33092     Document Type: Article

References (50)

1. Wobus AM, Boheler KR,. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005; 85: 635-678. (Pubitemid 40404638)
2. Hoffman LM, Carpenter MK,. Characterization and culture of human embryonic stem cells. Nat Biotechnol 2005; 23: 699-708. (Pubitemid 41716360)
3. Thomson JA, Itskovitz-Eldor O, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM,. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147. (Pubitemid 28516247)
4. Odorico JS, Kaufman DS, Thomson JA,. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001; 19: 193-204. (Pubitemid 32524540)
5. Hipp J, Atala A,. Sources of stem cells for regenerative medicine. Stem Cell Rev 2008; 4: 3-11.
6. Boheler KR, Czyz J, Tweedie D, Yang H-T, Anisimov SV, Wobus AM,. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002; 91: 189-201. (Pubitemid 34875673)
7. Kerr DA, Lladõ J, Shamblott MJ, Maragakis NJ, Iran DN, Crawford TO, Krishnan C, Dike S, Gearhart JD, Rothstein JD,. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J. Neurosci 2003; 23: 5131-5140. (Pubitemid 36793241)
8. Segev H, Fishman B, Ziskind A, Shulman M, Itskovitz-Eldor J,. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004; 22: 265-274. (Pubitemid 38736611)
9. Laake LWv, Passier R, Ouden Kd, Schreurs C, Monshouwer-Kloots J, Oostwaard DW-v, Echteld CJv, Doevendans PA, Mummery CL,. Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res 2009; 3: 106-112.
10. Xu C, Inokuma M, Denham J, Golds K, Kundu P, Gold J, Carpenter M,. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001; 19: 971-974. (Pubitemid 32947578)
11. Pera MF, Reubinoff B, Trounson A,. Human embryonic stem cells. J Cell Sci 2000; 113: 5-10. (Pubitemid 30066328)
12. Pedersen R,. Studies of in vitro differentiation with embryonic stem cells. Reprod Fertil Dev 1994; 6: 543-552.
13. Rohwedel J, Guan K, Wobus A,. Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 1999; 165: 190-202.
14. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N,. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000; 6: 88-95.
15. Rohwedel J, Sehlmeyer U, Shan J, Meister A, Wobus A,. Primordial germ cell-derived mouse embryonic germ (EG) cells in vitro resemble undifferentiated stem cells with respect to differentiation capacity and cell cycle distribution. Cell Biol Int 1996; 20: 579-587. (Pubitemid 26388082)
16. Trounson A,. The production and directed differentiation of human embryonic stem cells. Endocr Rev 2006; 27: 208-219.
17. Ding S, Schultz PG,. A role for chemistry in stem cell biology. Nat Biotechnol 2004; 22: 833-840. (Pubitemid 38886601)
18. Wobus AM, Rohwedel J, Maltsev V, Hescheler J,. In vitro differentiation of embryonic stem cells into cardiomyocytes or skeletal muscle cells is specifically modulated by retinoic acid. Roux's Arch Dev Biol 1994; 204: 36-45. (Pubitemid 24357820)
19. Bai H, Wang Z,. Directing human embryonic stem cells to generate vascular progenitor cells. Gene Ther 2008; 15: 89-95.
20. Reubinoff BE, Pera MF, Fong C-Y, Trounson A, Bongso A,. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18: 399-404. (Pubitemid 30217526)
21. Denning C, Allegrucci C, Priddle H, Barbadillo-Munoz MD, Anderson D, Self T, Smith NM, Parkin CT, Young LE,. Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int J Dev Biol 2006; 50: 27-37. (Pubitemid 43145107)
22. Burridge PW, Anderson D, Priddle H, Muñoz MDB, Chamberlain S, Allegrucci C, Young LE, Denning C,. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 2007; 25: 929-938. (Pubitemid 46572590)
23. Bauwens C, Peerani R, Niebruegge S, Woodhouse K, Kumacheva E, Husain M, Zandstra P,. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells 2008; 26: 2300-2310.
24. Kawaguchi J, Mee PJ, Smith AG,. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 2005; 36: 758-769. (Pubitemid 40616010)
25. Zhao X, Kim J, Cezar CA, Huebsch N, Leeb K, Bouhadird K, Mooney DJ,. Active scaffolds for on-demand drug and cell delivery. Proc Natl Acad Sci USA 2010; 108: 67-72.
26. Thuret S, Moon LDF, Gage FH,. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006; 7: 628-643. (Pubitemid 44106745)
27. Chen G, Ushida T, Tateishi T,. Scaffold design for tissue engineering. Macromol Biosci 2002; 2: 67-77. (Pubitemid 44790987)
28. Harris L, Kim B, Mooney D,. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998; 42: 396-402. (Pubitemid 28452514)
29. Yang S, Leong K-F, Du Z, Chua C-K,. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 2001; 7: 679-689. (Pubitemid 34042301)
30. Sheridan MH, Shea LD, Peters MC, Mooney DJ,. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000; 64: 91-102. (Pubitemid 30035310)
31. Anderson DG, Levenberg S, Langer R,. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol 2004; 22: 863-866. (Pubitemid 38886605)
32. Keselowsky B, Collard D, García A,. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res A 2003; 66: 247-259. (Pubitemid 37517224)
33. Charles R,., Nuttelmana, Danielle S.W., Benoita, Margaret C,., Tripodia, Anseth KS,. The effect of ethylene glycol methacrylate phosphate in PEG hydrogels on mineralization and viability of encapsulated hMSCs. Biomaterials 2006; 27: 1377-1386. (Pubitemid 41739563)
34. Benoit DSW, Schwartz MP, Durney AR, Anseth KS,. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008; 7: 816-823.
35. Langer R, Vacanti J,. Tissue engineering. Science 1993; 260: 920-926. (Pubitemid 23209960)
36. Ishaug-Riley S, Crane-Kruger G, Yaszemski M, Mikos A,. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 1998; 15: 1405-1412. (Pubitemid 28425460)
37. Lavik E, Langer R,. Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol 2004; 65: 1-8. (Pubitemid 39044304)
38. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R,. Controlled delivery systems for proteins based on poly(lactic glycolic acid) microspheres. Pharm Res 1991; 8: 713-720.
39. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R,. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003; 100: 12741-12746. (Pubitemid 37339969)
40. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Schöler H, Smith A,. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct. Cell 1998; 95: 379-391. (Pubitemid 28507326)
41. Andrews P, Damjanov I, Simon D, Banting G, Carlin C, Dracopoli N, Føgh J,. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984; 50: 147-162. (Pubitemid 14199076)
42. Schöler HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P,. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 1989; 8: 2543-2550. (Pubitemid 19273337)
43. McLean A, D'Amour K, Jones K, Krishnamoorthy M, Kulik M, Reynolds D, Sheppard A, Liu H, Xu Y, Baetge E, Dalton S,. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 2007; 25: 29-38. (Pubitemid 46052972)
44. Cai J, Chen J, Liu Y, Miura T, Luo Y, Loring JF, Freed WJ, Rao MS, Zeng X,. Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells 2006; 24: 516-530. (Pubitemid 44464756)
45. Battista S, Guarnieri D, Borselli C, Zeppetelli S, Borzacchiello A, Mayol L, Gerbasio D, Keene DR, Ambrosio L, Netti PA,. The effect of matrix composition of 3D constructs on embryonic stem cell differentiation. Biomaterials 2005; 26: 6194-6207. (Pubitemid 40826988)
46. Liu H, Collins SF, Suggs LJ,. Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials 2006; 27: 6004-6014. (Pubitemid 44414972)
47. Ashton RS, Banerjee A, Punyani S, Schaffer DV, Kane RS,. Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 2007; 28: 5518-5525. (Pubitemid 47599644)
48. Gravel M, Gross T, Vago R, Tabrizian M,. Responses of mesenchymalstemcell to chitosan-coralline composites microstructured using coralline as gas forming agent. Biomaterials 2006; 27: 1899-1906. (Pubitemid 41759484)
49. Flynn LE, Prestwich GD, Semple JL, Woodhouse KA,. Proliferation and differentiation of adipose-derived stem cells on naturally derived scaffolds. Biomaterials 2008; 29: 1862-1871.
50. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G,. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 2007; 104: 11298-11303. (Pubitemid 47175135)